Scientists Uncover 140 Genetic Clues Behind Age-Related Hearing Loss

Scientists Uncover 140 Genetic Clues Behind Age-Related Hearing Loss

A graph showing the correlation between male and female age groups, with the lower limit of range in severe dysplasia indicated by different colors, accompanied by explanatory text.

Scientists Uncover 140 Genetic Clues Behind Age-Related Hearing Loss

A groundbreaking genetic study has uncovered 140 new regions in the human genome linked to age-related hearing loss. Published in Nature Communications in 2026, the research triples the number of known susceptibility sites for the condition. Scientists analysed data from over half a million people, using a multi-ancestry approach to reveal previously hidden genetic risks.

Age-related hearing loss (ARHL) affects around one in three people over 65 and nearly half of those above 75. Despite its prevalence, the genetic roots of the condition have remained unclear—until now. The study combined vast genomic datasets from diverse populations, including well-documented audiometric records. Advanced computational models then helped pinpoint 140 genomic loci tied to ARHL, far exceeding earlier discoveries.

Many of the newly identified regions lie near genes essential for cochlear hair cell function, synaptic signalling, and ion channel regulation. Others point to pathways involved in mitochondrial health, oxidative stress, and inflammation. The findings suggest that chronic low-grade inflammation and cellular ageing play a key role in progressive hearing decline.

The study's multi-ancestry design was critical in overcoming biases found in earlier, less diverse research. By examining genetic patterns across different ethnic groups, the team not only uncovered population-specific risks but also improved the accuracy of polygenic risk scores (PRS). These scores can now better predict an individual's likelihood of developing ARHL, regardless of their background.

The research provides the most detailed genetic map of age-related hearing loss to date. It highlights the importance of inclusive genomic studies in understanding complex diseases. While no clinical treatments based on these findings have yet been developed, the study lays crucial groundwork for future investigations into ARHL prevention and management.

Neueste Nachrichten